Results 301 to 310 of about 250,417 (383)

Hormonal Counterregulation during standardized Hypoglycemia Test comparing Biosynthetic Human Proinsulin and Human Insulin [PDF]

open access: yes, 1985
Ball, P.   +4 more
core  

Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5‐Mediated ENO1 H3K4me3 Modification

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ulcerative colitis (UC) has become a prevalent global health concern. This study scrutinized the influence of Astragaloside IV (ASI) on DSS‐induced UC, with particular emphasis on the role of WDR5 in mediating ENO1 expression. The therapeutic efficacy of ASI was assessed in a mouse model of UC by evaluating disease activity index, pathology ...
Su‐Xiao Wu   +3 more
wiley   +1 more source

Improving blood glucose in late preterm and small for gestational age infants: the use of dextrose 40% gel. [PDF]

open access: yesFront Pediatr
Polo Perucchin P   +7 more
europepmc   +1 more source

Natural Peptides Versus Semaglutide: A Safer Approach to Obesity Management

open access: yesMedicine Advances, EarlyView.
This paper highlights that while semaglutide is effective for weight loss, it is associated with significant side effects, high cost, and muscle loss. In contrast, natural peptides such as BRP, BPC‐157, and MOTS‐c demonstrate promising anti‐obesity effects with fewer adverse outcomes, improved safety profiles, and potential affordability making them ...
Muhammad Affan Abid   +2 more
wiley   +1 more source

Liposomes Containing Tetraether Lipids and Cell‐Penetrating Peptides as Platform Technology for Oral Delivery of Peptides: A Comparative Study on GLP‐1 Analogs

open access: yesNano Select, EarlyView.
Liposomes functionalized with tetraether lipids and cell‐penetrating peptides are explored as a platform technology for oral peptide delivery. Therefore, peptide drugs (GLP‐1 analogs) with different sizes and physicochemical properties are used as model drugs.
Lorenz Herbster   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy